Learn more

DANDI BIOSCIENCE INC

Overview
  • Total Patents
    29
  • GoodIP Patent Rank
    54,311
  • Filing trend
    ⇧ 425.0%
About

DANDI BIOSCIENCE INC has a total of 29 patent applications. It increased the IP activity by 425.0%. Its first patent ever was published in 2016. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ALLERTEIN THERAPEUTICS LLC, GANSU LANYAO PHARMACEUTICAL CO LTD and HANFANG PHARMA CO LTD.

Patent filings per year

Chart showing DANDI BIOSCIENCE INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lim Yong Taik 21
#2 Kim Sun-Young 6
#3 Kim Kyun-Hwan 4
#4 Seong Baik Lin 4
#5 Byun Young Ho 4
#6 Lee Hye Min 4
#7 Park Eun Sook 4
#8 Park Yeong-Min 4
#9 Park Yeong Min 3
#10 Kim Kyun Hwan 2

Latest patents

Publication Filing date Title
WO2020175936A1 Polypeptide having antibacterial activity, composition for preventing or treating sepsis comprising same, and antibacterial composition
KR20200105423A Polypeptide having antibacterial activity, composition for preventing or treating sepsis comprising the same, and antibacterial composition
WO2018160026A1 Multi-domain vesicle comprising immunoactive material, production method therefor and immunomodulatory composition comprising same
WO2018160027A1 Multi-domain vesicle comprising immunosuppressive factor control material, production method therefor and immunomodulatory composition comprising same
KR20180101234A Multi domain vesicle, preparing method of the same, and immunomodulatory compostion comprising the same
WO2018147710A1 Nanoemulsion comprising imidazoquinoline-based material and use thereof
KR20180093813A Nanoemulsion containing imidazoquinoline-based material and uses thereof
KR101859223B1 Marker for detecting of high pathogenic influenza virus and use thereof
KR20180060639A Antiviral compositions against hepatitis B virus comprising interleukin-32 as an active ingredient